WHO ICTRP trial
ED95 Dose of Alfentanil Combined with Remimazolam for Effective Analgesia in…
ChiCTR2500103435 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500103435 |
|---|---|
| Public title | ED95 Dose of Alfentanil Combined with Remimazolam for Effective Analgesia in Painless Hysteroscopy: A Dose-Finding Study" |
| Scientific title | "ED95 Dose of Alfentanil Combined with Remimazolam for Effective Analgesia in Painless Hysteroscopy: A Dose-Finding Study" |
| Primary sponsor | The First Affiliated Hospital of Shan Tou University Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | patients undergoing hysteroscopy |
| Interventions | Remimazolam high-dose group (0.3 mg/kg):The initial dose of alfentanil is 10 ug/kg, and the sequential dose is 1 ug/kg.;Remimazolam low-dose group (0.2 mg/kg):The initial dose of alfentanil is 10 ug/kg, and the sequential dose is 1 ug/kg. |
| Registration date | May 29, 2025 |
| Target size | Remimazolam high-dose group (0.3 mg/kg):40;Remimazolam low-dose group (0.2… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: